Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04098146 · ClinicalTrials.gov registry record

Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis

A clinical trial of Mandibular Reconstruction and Segmental Mandibular Defects, sponsored by AO Innovation Translation Center.

Recruiting
Registry status
300
Enrollment target
19
Study locations

NCT04098146 is a study of Mandibular Reconstruction and Segmental Mandibular Defects that is actively recruiting participants, run by AO Innovation Translation Center. The registered enrollment target is 300 participants. The trial reports 19 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04098146, a study of Mandibular Reconstruction and Segmental Mandibular Defects, is actively recruiting participants, sponsored by AO Innovation Translation Center.

RECRUITING
Registry status
300 participants
Enrollment target
19
Study locations

Study Summary

Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 2 cm secondary to OSSC removal and drugs-induced osteonecrosis, and who require mandibular reconstruction.

Interventions

  • PROCEDURE Surgical Resection and Reconstruction

Study Locations (19)

Other

  • University Hospital RWTH Aachen - Aachen
  • University Hospital Charité - Berlin
  • Hannover Medical School - Hanover
  • Universitätsklinikum Heidelberg - Heidelberg
  • University Hospital Leipzig - Leipzig
  • Klinikum der LMU München - Munich
  • University Hospital Ulm - Ulm
  • Shimane University - Izumo
  • Erasmus University Medical Centre - Rotterdam
  • Luz Hospital - Lisbon
  • 12 de Octubre - Madrid
  • Uppsala University Hospital - Uppsala
  • University Hospital Basel - Basel

New York

  • Northwell Health Cancer Institute - New Hyde Park
  • Mount Sinai Hospital - New York

Florida

  • University of Florida College of Medicine - Jacksonville

Illinois

  • University of Illinois Chicago - Chicago

Texas

  • John Peter Smith Health Network - Fort Worth

Baden-Wurttemberg

  • Universitätsklinikum Tübingen - Tübingen

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-09-12
Est. Completion 2030-12-31

Sponsor

AO Innovation Translation Center

18 total trials

What the Registry Record Tells You About NCT04098146

The ClinicalTrials.gov registry entry for NCT04098146 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mandibular Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Surgical Resection and Reconstruction is the first listed.

NCT04098146 reports 19 study locations spanning 6 distinct geographic areas - top geographies include Other, New York, Florida.

Frequently Asked Questions

What is clinical trial NCT04098146 about?

NCT04098146 is a clinical study titled "Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis". Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 2 cm secondary to OSSC removal and drugs-induced osteonecrosis, and who require mandibular reconstruction.

What is the current status of trial NCT04098146?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2022-09-12. Estimated completion is 2030-12-31.

What conditions does trial NCT04098146 study?

This clinical trial studies the following conditions: Mandibular Reconstruction, Segmental Mandibular Defects.

What interventions are being tested in trial NCT04098146?

The interventions under investigation include: Surgical Resection and Reconstruction (PROCEDURE).

Who is sponsoring clinical trial NCT04098146?

This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04098146 being conducted?

This trial has 19 study locations across Florida, Illinois, New York, Texas, Baden-Wurttemberg. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mandibular Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.